Shanghai Hengrui Pharmaceutical Co., Ltd., Shanghai, China – FDA Inspections

Inspection records and compliance data for Shanghai Hengrui Pharmaceutical Co., Ltd. in Shanghai. 4 FDA inspections on record, 1 Form 483, last inspected October 25, 2024.

Company Profile

This profile covers Shanghai Hengrui Pharmaceutical Co., Ltd. based in Shanghai, China.

FDA Inspection History

FDA inspections: 4
OAI: 0
VAI: 2
NAI: 1
Unclassified: 1
Form 483s: 1
Warning letters: 0

First inspected September 6, 2013. Last inspected October 25, 2024.

FDA inspections (4)

Date	Result	FDA center(s)	Insp. #
October 25, 2024	Not classified	Human Drugs	1252840
July 20, 2018	NAI	Human Drugs · Drug Quality Assurance	1063523
March 27, 2015	VAI	Human Drugs · Drug Quality Assurance	921475
September 6, 2013	VAI	Human Drugs · Drug Quality Assurance	850208

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Other regulators (1)

China NMPA · 20 inspections · last October 10, 2018

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Hainan Simcere Pharmaceutical Co., Ltd.

Zhejiang Yongtai Pharmaceutical Co. Ltd

Novast Laboratories Ltd.

Haimen Pharma Co., Ltd.

Hangzhou Solipharma Co., Ltd.

Viwit Pharmaceutical Co., Ltd.

Chongqing Pharscin Pharmaceutical Co., Ltd. (Banqiao Road)

Fosun Pharma (Xuzhou) Co., Ltd.

2Y-Biopharma, Ltd.

Simcere Pharmaceutical Co., Ltd.